J&J Enters Robotic Surgery Market With Ottava System

Johnson & Johnson is making a bold push into robotic surgery with Ottava, its newly developed surgical robot designed to challenge established players in one of healthcare's fastest-growing and most profitable segments. The healthcare giant is expressing strong confidence that Ottava can carve out a meaningful share of a market that has long been dominated by specialized competitors.

Robotic surgery has emerged as a high-stakes battleground for medical device companies, offering hospitals precision tools that can reduce patient recovery times and improve surgical outcomes. J&J's entry signals that the conglomerate — already a powerhouse across pharmaceuticals and medical devices — sees robotic-assisted procedures as a critical growth vector for its future.

Read more Jindal Steel Builds World's Longest Steel Slag Road in India →

By launching Ottava, J&J is positioning itself to compete directly against entrenched rivals who have spent years building out their robotic surgery ecosystems, including training surgeons and integrating software platforms into hospital workflows. Breaking into such a market requires not just a competitive device, but a sustained commercial and educational infrastructure.

The move reflects a broader industry trend in which legacy healthcare companies are aggressively diversifying into high-margin surgical technology, driven by rising demand from hospitals seeking to modernize operating rooms and attract top surgical talent. For J&J, success with Ottava could open a substantial and recurring revenue stream tied to procedures, instruments, and service contracts.

Continue reading at CNBC.